BioRestorative Therapies (BRTX) Other Gross PP&E Adjustments (2016 - 2024)

BioRestorative Therapies (BRTX) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with -$7.2 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 50.44% year-over-year to -$7.2 million, compared with a TTM value of -$7.2 million through Dec 2024, up 50.44%, and an annual FY2024 reading of -$7.2 million, up 50.44% over the prior year.
  • Other Gross PP&E Adjustments was -$7.2 million for Q4 2024 at BioRestorative Therapies, down from -$39697.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$39697.0 in Q3 2024 and bottomed at -$14.6 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$2.6 million, with a median of -$401321.5 recorded in 2021.
  • The sharpest move saw Other Gross PP&E Adjustments crashed 172.48% in 2021, then surged 74.34% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$3.6 million in 2020, then tumbled by 172.48% to -$9.9 million in 2021, then fell by 29.51% to -$12.9 million in 2022, then fell by 13.35% to -$14.6 million in 2023, then surged by 50.44% to -$7.2 million in 2024.
  • Business Quant data shows Other Gross PP&E Adjustments for BRTX at -$7.2 million in Q4 2024, -$39697.0 in Q3 2024, and -$78146.0 in Q2 2024.